Vasomune Therapeutics Announces Poster Presentation at the American Thoracic Society International Conference

TORONTO--(BUSINESS WIRE)-- #ARDS--Vasomune selected to present peer-reviewed Phase 1 development data as a Late-Breaking scientific poster at the 2024 ATS conference.